Ting-Wan Lin Email & Phone Number

Taipei City, Taiwan

• Managed and directed special projects at Chairman' assignment
• Assisted the IPO project, including market assessments, the BP and prospectus formulation, and roadshows as the Chief Marketing Officer
• Coordinated international IVD sales of during pandemic: market survey, workflow establishment, resource allocation to meet dynamic requirements in a global emergency
• manage the drug manufacturing plan for the clinical development, including the management of the CDMO, troubleshooting of manufacturing issues, project timeline management and budget control

Taipei

• Numbers of Subordinate: 3-4Responsibility:
• Conducted fundamental technical and market assessments of potential products and propose strategic plan to fulfill the regulatory requirement of market approval and to accelerate product launch.
• Formulated business strategies and developed collaboration models with local or global pharmaceutical partners for early research, developing or commercial products.
• Managed projects and contracts, as well as controlled the budget and timeline by coordinating internal and external parties.
• Established the international connections and explored collaboration opportunities at the global and domestic conferences/business activities.
• Monitored the clinical development of H7N9 vaccine as the Medical AdvisorAchievement:

Taipei

• Numbers of Subordinate: 8-10Responsibility:
• Directed the development of pandemic influenza vaccines and supported the clinical development of other vaccines
• Identified the potential partners for the design of the vaccine factory and prepared all technical information to initiate the conceptual factory design.
• Maintained the successful communication with global partners in Korea, Japan, India, Thailand, and Europe, and prepared related business proposals and legal documents (MOU, term sheet, agreement) for collaboration.
• Reviewed the technical documents, and assisted the patent application. Achievement:
• Completed the Phase I clinical development of H5N1 pandemic influenza vaccine with team members.

Taipei

• Numbers of Subordinate: 8-10Responsibility:
• Directed all vaccine development including R&D, GMP production, preclinical and clinical development, and leaded the team to achieve the milestones of each project.
• Managed for all contracts, including contract negotiation, schedule control, resource allocation, cross-functional communication.
• Kept good communicate with the Center of Drug Evaluation (CDE) and sharped the roadmap of vaccine development.
• Reported to the board routinely, updated the progress of each project, and achieved consensus on overall business strategies with the board
• Explored potential business opportunities and conducted the market surveyAchievement:

Taipei

• Responsibility:
• Evaluated potential products (small molecules and biologics), including patents, medical aspects (preclinical and clinical), CMC, regulation, market, and pharmacoeconomics.
• Managed the preclinical studies, i.e. to design animal experiments, work with external parties (CRO or research teams)

Taipei

• PI: Dr. Andrew Hua-Jun Wang, Director of IBC
• Managed the lab daily operation
• Assisted experiments by crystallizing several essential proteins for functional studies, including phytase (myo-inositol hexaphosphate hydrolase), Sac7d and Sso10b (from Sulfolobus achaeabacteria) and its mutants.

Master'S Degree, Executive Master Of Business Administration

Doctor Of Philosophy - Phd, Molecular Biology And Biochemistry

• Engineered and determined the structures of the beta-subunit of acyl-CoA carboxylase (AccB and PccB) in Streptomyces coelicolor to.

Master'S Degree, Chemistry

• Determined trace metals in urine with a multi-element graphite furnace atomic absorption spectrometer.

Bachelor'S Degree, Chemistry